Search

Author/Creator Chang, Kwang-Yu

1. Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma. Issue 10 (24th April 2020)

Authors:
Yang, Wen-Bin; Hsu, Che-Chia; Hsu, Tsung-I; Liou, Jing-Ping; Chang, Kwang-Yu; Chen, Pin-Yuan; Liu, Jr-Jiun; Yang, Shung-Tai; Wang, Jia-Yi; Yeh, Shiu-Hwa; Chen, Ruei-Ming; Chang, Wen-Chang; Chuang, Jian-Ying
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 10(2020)
Page Start:
1439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers. (1st January 2021)

Authors:
Chang, Kwang-Yu; Chiang, Nai-Jung; Wu, Shang-Yin; Yen, Chia-Jui; Chen, Shang-Hung; Yeh, Yu-Min; Li, Chien-Feng; Feng, Xiaoxing; Wu, Katherine; Johnston, Amanda; Bomalaski, John S.; Wu, Bor-Wen; Gao, Jianjun; Subudhi, Sumit K.; Kaseb, Ahmed O.; Blando, Jorge M.; Yadav, Shalini S.; Szlosarek, Peter...
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗